Hyperglycemia-driven ROS accumulation promotes the overexpression of pro-inflammatory cytokines (e.g., TNF-α, IL-1β), matrix metalloproteinases (MMPs), and suppression of tissue inhibitors of metalloproteinases (TIMPs), ultimately resulting in extracellular matrix degradation [18,19]. This evidence concerns the gene IL1B and Hyperglycemia.